Sajjad Iraji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sajjad Iraji has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad-Reza Nazem-Zadeh
Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia
3 shared publications - Masoud Hassanpour
Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Seyed Mohammad Hossein Hosseini
University of Tehran
2 shared publications - Alireza Amouheidari
Isfahan Milad Hospital, Isfahan, Iran
1 shared publication - Amir Mohammad Msc Rezaei Rashnoudi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Fariba Davanian
Radiology Department, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran
1 shared publication
Latest Publications
- Open Access
- 30 August 2023
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 32 (2) , 15-26
Functional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate
Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS imaging. This modality links physiologic metabolic responses with available activity and measures absolute or relative concentrations of various metabolites. According to clinical evidence, the mitochondrial glycolysis pathway is disrupted in many nervous system disorders, especially Alzheimer disease, resulting in the activation of anaerobic glycolysis and an increased rate of lactate production. Our study evaluates fMRS with J-editing as a cutting-edge technique to detect lactate in Alzheimer disease. In this modality, functional activation is highlighted by signal subtractions of lipids and macromolecules, which yields a much higher signal-to-noise ratio and enables better detection of trace levels of lactate compared with other modalities. However, until now, clinical evidence is not conclusive regarding the widespread use of this diagnostic method. The complex machinery of cellular and noncellular modulators in lactate metabolism has obscured the potential roles fMRS imaging can have in dementia diagnosis. Recent developments in MRI imaging such as the advent of 7 Tesla machines and new image reconstruction methods, coupled with a renewed interest in the molecular and cellular basis of Alzheimer disease, have reinvigorated the drive to establish new clinical options for the early detection of Alzheimer disease. Based on the latter, lactate has the potential to be investigated as a novel diagnostic and prognostic marker for Alzheimer disease.
- 30 August 2023
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 32 (2) , 15-26
Open AccessFunctional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate
Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS imaging. This modality links physiologic metabolic responses with available activity and measures absolute or relative concentrations of various metabolites. According to clinical evidence, the mitochondrial glycolysis pathway is disrupted in many nervous system disorders, especially Alzheimer disease, resulting in the activation of anaerobic glycolysis and an increased rate of lactate production. Our study evaluates fMRS with J-editing as a cutting-edge technique to detect lactate in Alzheimer disease. In this modality, functional activation is highlighted by signal subtractions of lipids and macromolecules, which yields a much higher signal-to-noise ratio and enables better detection of trace levels of lactate compared with other modalities. However, until now, clinical evidence is not conclusive regarding the widespread use of this diagnostic method. The complex machinery of cellular and noncellular modulators in lactate metabolism has obscured the potential roles fMRS imaging can have in dementia diagnosis. Recent developments in MRI imaging such as the advent of 7 Tesla machines and new image reconstruction methods, coupled with a renewed interest in the molecular and cellular basis of Alzheimer disease, have reinvigorated the drive to establish new clinical options for the early detection of Alzheimer disease. Based on the latter, lactate has the potential to be investigated as a novel diagnostic and prognostic marker for Alzheimer disease.
- Open Access
- 17 August 2022
- Published by Elsevier in Neuroscience Informatics
- Vol. 2 (4)
CTtrack: A CNN+Transformer-based framework for fiber orientation estimation & tractography
- 17 August 2022
- Published by Elsevier in Neuroscience Informatics
- Vol. 2 (4)
Open AccessCTtrack: A CNN+Transformer-based framework for fiber orientation estimation & tractography
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Transformer-Based Framework for Fiber Orientation Estimation & Tractography
In recent years, multiple data-driven fiber orientation distribution function (fODF) estimation algorithms and automatic tractography pipelines have been proposed to address the limitations of traditional methods. However, these approaches lack precision and generalizability. To tackle these shortcomings, we introduce a transformer-based pipeline to estimate fODFs and perform tractography. In this approach, a convolutional neural network (CNN) module is employed to project the resampled diffusion-weighted magnetic resonance imaging (DW-MRI) data to a lower dimension. Then, a transformer model estimates the fiber orientation distribution functions using the projected data within a local block around each voxel. The proposed model represents the extracted fODFs by spherical harmonics coefficients. The predicted fiber ODFs can be used for both deterministic and probabilistic tractography. Our pipeline was tested in terms of the precision and robustness in estimating fODFs and performing tractography using both simulated and real diffusion data. The Tractometer tool was employed to compare our method with the classical and data-driven tractography approaches. The qualitative and quantitative assessments illustrate the competitive performance of our framework compared to other available algorithms.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessTransformer-Based Framework for Fiber Orientation Estimation & Tractography
In recent years, multiple data-driven fiber orientation distribution function (fODF) estimation algorithms and automatic tractography pipelines have been proposed to address the limitations of traditional methods. However, these approaches lack precision and generalizability. To tackle these shortcomings, we introduce a transformer-based pipeline to estimate fODFs and perform tractography. In this approach, a convolutional neural network (CNN) module is employed to project the resampled diffusion-weighted magnetic resonance imaging (DW-MRI) data to a lower dimension. Then, a transformer model estimates the fiber orientation distribution functions using the projected data within a local block around each voxel. The proposed model represents the extracted fODFs by spherical harmonics coefficients. The predicted fiber ODFs can be used for both deterministic and probabilistic tractography. Our pipeline was tested in terms of the precision and robustness in estimating fODFs and performing tractography using both simulated and real diffusion data. The Tractometer tool was employed to compare our method with the classical and data-driven tractography approaches. The qualitative and quantitative assessments illustrate the competitive performance of our framework compared to other available algorithms.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 6616992
Early Detection of Radiation‐Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low‐Grade Glioma
Purpose. To compare the sensitivity of MRS metabolites and MoCA and ACE‐R cognitive tests in the detection of radiation‐induced injury in low grade glioma (LGG) patients in early and early delayed postradiation stages. Methods. MRS metabolite ratios of NAA/Cr and Cho/Cr, ACE‐R and MoCA cognitive tests, and dosimetric parameters in corpus callosum were analyzed during RT and up to 6‐month post‐RT for ten LGG patients. Results. Compared to pre RT baseline, a significant decline in both NAA/Cr and Cho/Cr in the corpus callosum was seen at the 4th week of RT, 1, 3, and 6‐month post‐RT. These declines were detected at least 3 months before the detection of declines in cognitive functions by ACE‐R and MoCA tools. Moreover, NAA/Cr alterations at 4th week of RT and 1‐month post‐RT were significantly negatively correlated with the mean dose received by the corpus callosum, as well as the corpus callosum 40 Gy dose volume, i.e., the volume of the corpus callosum receiving a dose greater than 40 Gy. Conclusion. MRS‐based biomarkers may be more sensitive than the state‐of‐the‐art cognitive tests in the prediction of postradiation cognitive impairments. They would be utilized in treatment planning and dose sparing protocols, with a specific focus on the corpus callosum in the radiation therapy of LGG patients.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 6616992
Open AccessEarly Detection of Radiation‐Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low‐Grade Glioma
Purpose. To compare the sensitivity of MRS metabolites and MoCA and ACE‐R cognitive tests in the detection of radiation‐induced injury in low grade glioma (LGG) patients in early and early delayed postradiation stages. Methods. MRS metabolite ratios of NAA/Cr and Cho/Cr, ACE‐R and MoCA cognitive tests, and dosimetric parameters in corpus callosum were analyzed during RT and up to 6‐month post‐RT for ten LGG patients. Results. Compared to pre RT baseline, a significant decline in both NAA/Cr and Cho/Cr in the corpus callosum was seen at the 4th week of RT, 1, 3, and 6‐month post‐RT. These declines were detected at least 3 months before the detection of declines in cognitive functions by ACE‐R and MoCA tools. Moreover, NAA/Cr alterations at 4th week of RT and 1‐month post‐RT were significantly negatively correlated with the mean dose received by the corpus callosum, as well as the corpus callosum 40 Gy dose volume, i.e., the volume of the corpus callosum receiving a dose greater than 40 Gy. Conclusion. MRS‐based biomarkers may be more sensitive than the state‐of‐the‐art cognitive tests in the prediction of postradiation cognitive impairments. They would be utilized in treatment planning and dose sparing protocols, with a specific focus on the corpus callosum in the radiation therapy of LGG patients.